Duke Rohlen, CEO and director of Ajax Health, co-founder and CEO of Spirox Inc., explains how he’s combining his expertise, connections, and experience exiting Medtech companies with KKR’s capital to devise a new way to run start-ups.

ReCor’s Weiss Sees Medtech’s Rebound, Talks Renal Denervation and Innovative Strategic Financing

A weekly conversation with the innovators who will change how health care is delivered.